$GNLX

$2.05 +$0.14 (7.33%) Close

$GNLX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$GNLX Management Team

Mr. Matthew Pulisic

Chief Financial Officer

Age 41

Compensation -

Sex Male

Mr. Eric Groen

General Counsel

Corporate Secretary

Chief Compliance Officer

Head of Business Development

Age 54

Compensation -

Sex Male

Mr. Thomas Zindrick

Chairman of the Board

President

Chief Executive Officer

Age 66

Compensation $1.473M USD

Sex Male

Dr. Tony Yu

Senior Vice President - Clinical Development

Age 54

Compensation -

Sex Male

Dr. Joseph Cappello

Chief Technical Officer

Age 68

Compensation $601.8K USD

Sex Male

Mr. Ralph Smalling

Head - Regulatory

Age 69

Compensation -

Sex Male

Dr. Ankit Bhargava

IR Contact Officer

Age -

Compensation -

Sex Male

Dr. Jason Litten

Chief Medical Officer

Age 52

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Matthew Pulisic Chief Financial Officer	41	-	Male
Mr. Eric Groen General Counsel Corporate Secretary Chief Compliance Officer Head of Business Development	54	-	Male
Mr. Thomas Zindrick Chairman of the Board President Chief Executive Officer	66	$1.473M USD	Male
Dr. Tony Yu Senior Vice President - Clinical Development	54	-	Male
Dr. Joseph Cappello Chief Technical Officer	68	$601.8K USD	Male
Mr. Ralph Smalling Head - Regulatory	69	-	Male
Dr. Ankit Bhargava IR Contact Officer	-	-	Male
Dr. Jason Litten Chief Medical Officer	52	-	Male

Board of Directors

From the proxy statement filed Apr 29, 2026

Directors

serving now

Independent

4 of 4

stated in the proxy; 1 not stated

Average tenure

11.6 years

from year joined

CEO also chairs the board

Yes

Thomas D. Zindrick, J.D.

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
John Smither	73	2023 3 years	Independent	None stated	NewAmsterdam Pharma	Not stated
Mary Mirabelli	69	2021 5 years	Independent	None stated	None stated	Not stated
John Thomas, Ph.D.	68	2002 24 years	Independent	None stated	None stated	Not stated
James L. Tyree Lead independent director	73	2012 14 years	Independent	None stated	None stated	$264,009
Thomas D. Zindrick, J.D. Board chair, CEO	67	2014 12 years	Not stated	None stated	None stated	Paid as CEO

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 29, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$GNLX Management Team

Mr. Matthew Pulisic

Mr. Eric Groen

Mr. Thomas Zindrick

Dr. Tony Yu

Dr. Joseph Cappello

Mr. Ralph Smalling

Dr. Ankit Bhargava

Dr. Jason Litten

Board of Directors

Related-party transactions

No related-party transactions disclosed